Notably, patients with HBV-related HCC exhibit higher CD4+ T cell levels than those with chronic hepatitis or healthy individuals, although these levels decline in advanced stages, particularly within the tumor core and peritumoral regions, potentially due to selective recruitment aimed at immune evasion [61]. Here, CD4 is linked to hepatocellular carcinoma.